STUDY ON THE EFFECTS OF METHYL PREDNISOLONE AS PULSE THERAPY IN PATIENTS WITH TUBERCULOUS MENINGITIS IN RIMS RANCHI, JHARKHAND, INDIA
Author:
Kumari Neelam1, Sharma Bhushan2, Guria Rishi tauhin3, Kumar Sanjay4
Affiliation:
1. Senior Resident, Department of Medicine, Rajendra Institute of Medical Sciences (RIMS),Ranchi. 2. Professor, Department of Medicine, Rajendra Institute of Medical Sciences (RIMS),Ranchi. 3. Associate Professor, Department of Medicine, Rajendra Institute of Medical Sciences (RIMS),Ranchi. 4. Associate Professor, Department of Forensic Medicine and Toxicology, Rajendra Institute of Medical Sciences (RIMS), Ranchi.
Abstract
The common presentation of tuberculosis is common but uncommon presentation of tuberculosis is not so uncommon. Mycobacterium tuberculosis can affect any part of the body, at any age and in any form. Tuberculous meningitis (TBM) is a serious form of tuberculosis that affects meninges (coverings of brain and spinal cord) which are responsible for many deaths (1). It is associated with high mortality and morbidity. The steroids appear to reduce mortality in the patients of tuberculous meningitis, regardless of the MRC stage at presentation. Corticosteroids have been used as an adjunct to anti-tuberculous drugs to treat patients with tuberculous meningitis (3,4,5,6).
The present study has been undertaken to evaluate the effects of short course, high dose of intravenous methylprednisolone (pulse therapy) versus intravenous dexamethasone (in conventional dose) as an adjunct to anti-tuberculous treatment, on the clinical, biochemical and radiological outcome in patients with tuberculous meningitis.
A total of 94 TBM patients were enrolled for this study. 49 TBM patients as a case were given IV infusion of high dose methylprednisolone (1g/day for 5 days) and forty five TBM patients as control were given IV dexamethasone in conventional dose (0.4mg/kg/day divided in 3-4 doses) along with antituberculous therapy. Detailed clinical, biochemical, microbiological and radiological evaluation were performed and findings were evaluated.
TBM is considered as a serious extrapulmonary form of TB (Tuberculosis) and should arise suspicion in mind of clinicians based on clinical findings for prompt diagnosis and treatments. In various studies it has been shown that corticosteroids used for longer periods in TBM patients along with antituberculous drugs, were associated with reduced mortality and morbidity but increased adverse effects. In the present study, methylpredisolone used as a pulse therapy showed significant improvement in clinical profile, laboratory findings and radiological outcome.
Publisher
World Wide Journals
Reference29 articles.
1. 1. Tandon PN, Bhatia R, Bhargava S. Tuberculous meningitis. In: Harris AA editor(s). Handbook of Clinical Neurology. Vol. 8, Amsterdam: Elsevier Science Publishers, 1988:195‐226. 2. 2. Prasad K, Singh MB, Ryan H, 2016. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 4: 1–64. 3. 3. Centers for Disease Control and Prevention. Treatment of Tuberculosis, American Thoracic Society, CDC, and Infectious Diseases Society of America. MMWR 2003;52(RR-11):1-77. 4. 4. Thwaites G, Fisher M, Hemingway C, Scott G, Solomon T, Innes J, British Infection Society. British Infection Society guidelines for the diagnosis and treatment of tuberculosis of the central nervous system in adults and children. Journal of Infection 2009;59(3):167-87. 5. 5. Working Group of the Clinical Practice Guideline on the Diagnosis, Treatment and Prevention of Tuberculosis. Centro Cochrane Iberoamericano (Iberoamerican Cochrane Centre), coordinator. Clinical Practice Guideline on the Diagnosis, Treatment and Prevention of Tuberculosis. Quality Plan for the Spanish National Healthcare System of the Spanish Ministry for Health, Social Policy and Equality; Agència d’Informació, Avaluació i Qualitat en Salut de Catalunya (AIAQS - Agency for Information, Evaluation, and Quality in Health of Catalonia). Ministry of Science and Innovation, Spain, 2010.
|
|